Global logistics solutions firm DHL Supply Chain has opened a new distribution centre for the life sciences and healthcare industry in Mumbai.
This is part of its strategy to extend its life sciences network to emerging markets across the globe.
The unit is expected to give a boost to the Indian pharmaceutical and medical devices industry, as it has facilities for warehousing, distribution and clinical trial services.
The multi-customer distribution centre is spread over 56,000 sq mt.
Mr Vikas Anand, COO of DHL Supply Chain India, said the new platform will enable the company to provide advanced logistics and warehousing services for the life sciences and health care industry.
“We have the capabilities to distribute to wholesalers, pharmacists and hospitals from the Mumbai centre based on customer demands,” he added.
The facility will be offering a complete portfolio of services to manufacturers of pharmaceutical products, ranging from order management to warehousing and distribution.
It also offers specific solutions such as postponement services, clinical trials logistics and order-to-cash.
“Looking to 2015 and beyond, India, China and other emerging markets are expected to be the key drivers of growth in the pharmaceutical and medical device sectors. With this warehouse, we take another step in pursuing DHL's global industry sector strategy,” Mr Angelos Orfanos, President and Global Head of Life Sciences & Healthcare, DHL Customer Solutions & Innovation, said.
DHL operates over 150 Life Sciences facilities worldwide to support its global life sciences and healthcare strategy.
The emerging markets are likely to contribute about 75 per cent of global pharmaceutical sales growth by 2015.
According to IMS Research, India's rank as a pharmaceutical market is expected to increase 12th in 2010 to 8th in 2015.